👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Colgate-Palmolive stock brushes all-time high at $106.75

Published 2024/09/03, 15:36
CL
-

In a remarkable display of market resilience, Colgate-Palmolive Company (NYSE:CL)'s stock has reached an all-time high, cresting at $106.75. This peak represents not just a 52-week triumph but also the highest price level the company's shares have ever achieved. Investors have been smiling wide as the consumer goods giant, known for its oral care products, among other household staples, has seen an impressive 1-year change, with stock value surging by 45.3%. This bullish trend underscores the company's robust financial health and the strong consumer demand for its products, even amidst a challenging economic landscape.

"In other recent news, Colgate-Palmolive Company has demonstrated robust financial performance, with a return to mid single-digit volume growth and expanding gross margins in the second quarter of 2024. TD Cowen, Jefferies, and Evercore ISI have all adjusted their price targets for the company, reflecting its strong growth prospects and high return on invested capital. The company's success has been attributed to innovative product launches, strategic marketing, and robust execution in developing markets, particularly in Latin America. TD Cowen revised its earnings per share (EPS) growth estimate for Colgate-Palmolive upward to 11.1% from 10.5%, while Evercore ISI increased its EPS estimates for the years 2024 and 2025. Despite potential industry deceleration in Europe, Colgate-Palmolive maintained solid volume growth, with notable contributions from the Hill's business segment. These are among the recent developments for the multinational consumer products company, which continues to make significant strides in its financial performance."

InvestingPro Insights

In light of Colgate-Palmolive's recent stock performance, several metrics and InvestingPro Tips highlight the company's current market position. With a market capitalization of $86.95 billion and a P/E ratio of 30.76, the company showcases significant investor confidence. The adjusted P/E ratio for the last twelve months as of Q2 2024 is at 29.93, reflecting a stable valuation in comparison to near-term earnings growth. Moreover, Colgate-Palmolive's gross profit margin stands at an impressive 59.7%, indicating strong profitability in its operations.

InvestingPro Tips suggest that Colgate-Palmolive has raised its dividend for 34 consecutive years, which is a testament to its commitment to shareholder returns. Additionally, the company's stock is currently trading near its 52-week high, with a price percentage of 99.79% of that peak. This is supported by a robust 1-year price total return of 48.8%, showcasing the stock's impressive return over the past year. For investors seeking further insights, there are over 14 additional InvestingPro Tips available, offering a deeper analysis of Colgate-Palmolive's financials and market performance.

These insights, especially the consistent dividend growth and strong gross profit margins, align with the company's recent stock achievements and provide a comprehensive view for investors considering Colgate-Palmolive in their portfolio. For a more detailed analysis, interested parties are encouraged to explore the additional tips and metrics on InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.